Stockscreener 앱 받기
1.80
0.55%
-0.01
시간 외 거래:
1.80
Tscan Therapeutics Inc 주식(TCRX)의 최신 뉴스
Full technical analysis of TScan Therapeutics Inc. stockWeekly Stock Summary & Daily Volume Surge Signals - Newser
HC Wainwright Expects Higher Earnings for TScan Therapeutics - Defense World
Detecting price anomalies in TScan Therapeutics Inc. with AIJuly 2025 Pullbacks & Weekly Chart Analysis and Guides - Newser
Real time scanner hits for TScan Therapeutics Inc. explainedPortfolio Profit Report & Weekly Top Performers Watchlists - Newser
What recovery options are there for TScan Therapeutics Inc.Portfolio Growth Summary & Stock Timing and Entry Methods - Newser
TScan Therapeutics Inc. Shows Support at Fibonacci LevelWatch List & Technical Entry and Exit Alerts - sundaytimes.kr
What are analysts’ price targets for TScan Therapeutics Inc.2025 Winners & Losers & Real-Time Volume Analysis - mustnews.co.kr
Visualizing TScan Therapeutics Inc. stock with heatmapsPortfolio Profit Report & Daily Oversold Bounce Ideas - Newser
TScan Therapeutics, Inc. (TCRX) Reports Q2 Loss, Beats Revenue Estimates - MSN
Statistical indicators supporting TScan Therapeutics Inc.’s strengthGDP Growth & AI Forecast Swing Trade Picks - Newser
Measuring TScan Therapeutics Inc.’s beta against major indices2025 Market Overview & Precise Swing Trade Entry Alerts - Newser
What machine learning models say about TScan Therapeutics Inc.Layoff News & Smart Swing Trading Techniques - Newser
What Fibonacci levels say about TScan Therapeutics Inc. reboundJuly 2025 News Drivers & Weekly High Return Stock Forecasts - Newser
Combining machine learning predictions for TScan Therapeutics Inc.Trade Risk Report & AI Enhanced Trade Execution Alerts - Newser
Equities Analysts Offer Predictions for TCRX Q3 Earnings - Defense World
Intrinsic Value of TScan Therapeutics Inc. Stock: Is It Undervalued or OvervaluedMarket Performance Recap & Low Risk Growth Stock Ideas - Newser
Should you hold or exit TScan Therapeutics Inc. now2025 Breakouts & Breakdowns & Free Long-Term Investment Growth Plans - Newser
TScan Therapeutics Inc. stock trend forecastMarket Trend Report & Growth Focused Entry Reports - Newser
What makes TScan Therapeutics Inc. stock price move sharplyGold Moves & Free Technical Pattern Based Buy Signals - thegnnews.com
Is TScan Therapeutics Inc. a momentum stockDip Buying & Low Risk Entry Point Guides - thegnnews.com
TScan Therapeutics (NASDAQ:TCRX) Will Have To Spend Its Cash Wisely - Yahoo Finance
Order flow analysis tools used on TScan Therapeutics Inc.Options Play & Advanced Swing Trade Entry Plans - Newser
Evaluating TScan Therapeutics Inc. with trendline analysisWeekly Trade Summary & Growth-Oriented Investment Plans - Newser
TScan Therapeutics Inc. recovery potential after sell off2025 Big Picture & Entry Point Confirmation Signals - Newser
TScan Therapeutics’s SWOT analysis: biotech stock faces pivotal year - Investing.com
TScan Therapeutics’s SWOT analysis: biotech stock faces pivotal year By Investing.com - Investing.com Nigeria
How TScan Therapeutics Inc. stock performs during market volatilityJuly 2025 WrapUp & Precise Trade Entry Recommendations - beatles.ru
TScan Therapeutics (TCRX) Gets a Buy from TD Cowen - The Globe and Mail
What moving averages say about TScan Therapeutics Inc.Portfolio Risk Summary & High Win Rate Trade Tips - Newser
Volatility clustering patterns for TScan Therapeutics Inc.2025 Key Highlights & High Accuracy Buy Signal Tips - Newser
TScan Therapeutics (NASDAQ:TCRX) Given “Outperform” Rating at Wedbush - Defense World
TScan Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewswire
0.41%
0.88%
자본화:
|
볼륨(24시간):